FP
Flagship Pioneering Portfolio holdings
AUM
$268M
This Quarter Return
-41.25%
1 Year Return
-54.4%
3 Year Return
-51.2%
5 Year Return
+66.7%
10 Year Return
–
AUM
$334M
AUM Growth
+$334M
(-44%)
Cap. Flow
-$2.78M
Cap. Flow
% of AUM
-0.83%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
–
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
|
$2.78M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Moderna
MRNA
$9.37B
| $193M | 57.63% |
4,632,149
| – | – |
|
2
Foghorn Therapeutics
FHTX
$286M
| $59.8M | 17.9% |
12,674,120
| – | – |
|
3
Sana Biotechnology
SANA
$777M
| $40.8M | 12.19% |
25,001,856
| – | – |
|
|
OMGA
4
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $21.8M | 6.52% |
29,225,579
| – | – |
|
5
Seres Therapeutics
MCRB
$166M
| $19.3M | 5.76% |
23,117,045
| – | – |
|
|
SYRS
6
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| – | – |
-1,293,849
| Closed | -$2.78M |
|